Biotech scaleup NADMED launches $30K global award to advance innovation in cellular health
Biotech scaleup NADMED launches $30K global award to advance innovation in cellular health As scientists seek to understand the molecular basis of energy production, ageing, and disease, one area remains especially elusive: cellular redox metabolites. Finnish biotech company NADMED is launching the NADMED Award 2026, a global call for innovators
